China Biosimilars Market (2024-2030) Outlook | Companies, Revenue, Forecast, Share, Industry, Trends, Growth, Analysis, Size & Value

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069940 Publication Date: Jun 2021 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Key Highlights of the Report:

  • China Biosimilars Market Outlook
  • Market Size of China Biosimilars Market, 2020
  • Forecast of China Biosimilars Market, 2030
  • Historical Data and Forecast of China Biosimilars Revenues & Volume for the Period 2020 - 2030
  • China Biosimilars Market Trend Evolution
  • China Biosimilars Market Drivers and Challenges
  • China Biosimilars Price Trends
  • China Biosimilars Porter's Five Forces
  • China Biosimilars Industry Life Cycle
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of China Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • China Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • China Biosimilars Top Companies Market Share
  • China Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • China Biosimilars Company Profiles
  • China Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Biosimilars Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Biosimilars Market Revenues & Volume, 2020 & 2030F

3.3 China Biosimilars Market - Industry Life Cycle

3.4 China Biosimilars Market - Porter's Five Forces

3.5 China Biosimilars Market Revenues & Volume Share, By Form, 2020 & 2030F

3.6 China Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.7 China Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2030F

4 China Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 China Biosimilars Market Trends

6 China Biosimilars Market, By Types

6.1 China Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 China Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 China Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 China Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 China Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 China Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 China Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 China Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 China Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 China Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 China Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 China Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 China Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 China Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 China Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 China Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 China Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 China Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 China Biosimilars Market Import-Export Trade Statistics

7.1 China Biosimilars Market Export to Major Countries

7.2 China Biosimilars Market Imports from Major Countries

8 China Biosimilars Market Key Performance Indicators

9 China Biosimilars Market - Opportunity Assessment

9.1 China Biosimilars Market Opportunity Assessment, By Product, 2020 & 2030F

9.2 China Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2030F

9.3 China Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2030F

10 China Biosimilars Market - Competitive Landscape

10.1 China Biosimilars Market Revenue Share, By Companies, 2020

10.2 China Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All